1. Home
  2. LAES vs ALDX Comparison

LAES vs ALDX Comparison

Compare LAES & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$4.21

Market Cap

366.0M

Sector

Technology

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.56

Market Cap

293.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
ALDX
Founded
2022
2004
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.0M
293.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
LAES
ALDX
Price
$4.21
$4.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$9.50
AVG Volume (30 Days)
14.4M
971.9K
Earning Date
12-11-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,978,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$36.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$1.14
52 Week High
$11.00
$7.20

Technical Indicators

Market Signals
Indicator
LAES
ALDX
Relative Strength Index (RSI) 41.90 39.04
Support Level $4.45 $4.67
Resistance Level $5.09 $5.04
Average True Range (ATR) 0.38 0.29
MACD 0.05 -0.05
Stochastic Oscillator 33.59 3.42

Price Performance

Historical Comparison
LAES
ALDX

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: